Diranersen clinical trials
Also written ISIS 814907 and BIIB080.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses diranersen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses diranersen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled Diranersen (BIIB080) Co-administered With Diranersen in Healthy AdultsCompletedPhase 1BiogenNCT06454721Written as Diranersen
- A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of AgeActive, not recruitingPhase 2BiogenNCT05399888Written as Diranersen
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's DiseaseCompletedPhase 1Ionis Pharmaceuticals, Inc.NCT03186989Written as IONIS MAPTRx
Codes
What other systems call diranersen · ClinicalTrials.gg INT015806
- UNII (FDA) 96J3L33PWDDIRANERSENOne source FDA
- NCI Thesaurus C216018DiranersenOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 96J3L33PWD | DIRANERSEN | One source FDA |
| NCI Thesaurus | C216018 | Diranersen | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.